SRPT: Sarepta Therapeutics, Inc. Stock

by  •  • Comments Off on SRPT: Sarepta Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4,881.68
Enterprise Value ($M) 5,007.39
Book Value ($M) 1,527.74
Book Value / Share 15.74
Price / Book 3.20
NCAV ($M) 638.03
NCAV / Share 6.58
Price / NCAV 7.65

Profitability (mra)
Return on Invested Capital (ROIC) 0.08
Return on Assets (ROA) 0.07
Return on Equity (ROE) 0.24

Liquidity (mrq)
Quick Ratio 3.18
Current Ratio 4.20

Balance Sheet (mrq) ($M)
Current Assets 3,073.46
Assets 3,963.17
Liabilities 2,435.43
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,901.98
Operating Income 218.08
Net Income 235.24
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -205.79
Cash from Investing 755.56
Cash from Financing 124.81

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Capital International Investors 9.30 39.80
11-14 13G/A Janus Henderson Group Plc 4.60 -18.47
06-07 13G/A BlackRock, Inc. 10.70 61.55

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 380,638 3,842,166 9.91
2025-04-10 485,267 2,665,319 18.21
2025-04-09 829,321 3,906,712 21.23
2025-04-08 868,038 3,236,922 26.82
2025-04-07 539,200 3,158,861 17.07

(click for more detail)

Similar Companies
SLRN – Acelyrin, Inc. SNDX – Syndax Pharmaceuticals, Inc.
SPRO – Spero Therapeutics, Inc. SRRK – Scholar Rock Holding Corporation
STOK – Stoke Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io